| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,116 |
12,196 |
$1.11M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,702 |
4,255 |
$542K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,718 |
3,560 |
$389K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,507 |
3,300 |
$364K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,365 |
2,921 |
$311K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,293 |
2,128 |
$258K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,502 |
6,625 |
$81K |
| 92551 |
|
8,020 |
7,407 |
$75K |
| 90686 |
|
3,225 |
2,934 |
$67K |
| 90698 |
|
1,912 |
1,767 |
$41K |
| 90670 |
|
1,800 |
1,656 |
$38K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
819 |
719 |
$31K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,593 |
1,452 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,037 |
801 |
$22K |
| D1206 |
Topical application of fluoride varnish |
837 |
821 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
441 |
383 |
$17K |
| 99173 |
|
6,872 |
6,356 |
$17K |
| 96161 |
|
5,978 |
5,340 |
$16K |
| 90633 |
|
736 |
700 |
$16K |
| 90680 |
|
708 |
643 |
$15K |
| 96127 |
|
3,150 |
2,898 |
$14K |
| 90744 |
|
463 |
429 |
$10K |
| 90710 |
|
331 |
314 |
$7K |
| 96160 |
|
2,784 |
2,522 |
$7K |
| 99051 |
|
941 |
747 |
$7K |
| 0071A |
|
212 |
180 |
$7K |
| 90651 |
|
276 |
252 |
$6K |
| 90677 |
|
263 |
229 |
$5K |
| 90734 |
|
261 |
243 |
$5K |
| 0072A |
|
145 |
134 |
$5K |
| 87428 |
|
136 |
122 |
$4K |
| 90656 |
|
163 |
156 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
216 |
184 |
$2K |
| 90619 |
|
77 |
68 |
$2K |
| 90715 |
|
67 |
62 |
$1K |
| 90661 |
|
77 |
76 |
$1K |
| 1000F |
|
1,792 |
1,656 |
$1K |
| 87807 |
|
93 |
82 |
$938.71 |
| 83655 |
|
64 |
61 |
$681.39 |
| 99050 |
|
65 |
61 |
$666.20 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
18 |
$423.72 |
| 81003 |
|
467 |
409 |
$358.32 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
15 |
15 |
$351.90 |
| 85018 |
|
63 |
60 |
$138.26 |
| 4145F |
|
53 |
51 |
$136.92 |
| 85014 |
|
50 |
47 |
$113.90 |
| 99174 |
|
16 |
12 |
$55.64 |
| G9920 |
Screening performed and negative |
1,280 |
1,221 |
$12.35 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
268 |
262 |
$0.00 |
| 99000 |
|
42 |
21 |
$0.00 |